OSR Health, Inc. Chief Financial Officer Gihyoun Bang filed a Form 4 on November 19, 2026, disclosing the acquisition of 440,137 shares of common stock on October 29, 2026, in settlement of accrued unpaid salary under the company's 2025 Omnibus Incentive Plan.
Key Highlights
- Reporting person: Gihyoun Bang, Chief Financial Officer of OSR Health, Inc. (OTC:OSRH)
- Transaction date: October 29, 2026; 440,137 shares of common stock acquired (transaction code A)
- Price per share: $0.2272, equal to 115% of the volume-weighted average price for the 15 trading days ended October 28, 2026, according to the filing
- Purpose: Shares were issued in settlement of accrued unpaid salary under the OSR Health, Inc. 2025 Omnibus Incentive Plan
- Approval: The award was approved by the issuer's Board of Directors and Compensation Committee and is reported as exempt under Rule 16b-3(d)
- Lock-up: The shares are subject to a six-month contractual lock-up from the grant date
- Beneficial ownership following transaction: 440,137 shares held directly
OSR Health CFO Receives Shares in Lieu of Accrued Salary at $0.2272
According to the Form 4 filed with the SEC on November 19, 2026, Gihyoun Bang, the Chief Financial Officer of OSR Health, Inc. (OTC:OSRH), acquired 440,137 shares of the company's common stock on October 29, 2026. The filing indicates the shares were issued under the OSR Health, Inc. 2025 Omnibus Incentive Plan as settlement for accrued unpaid salary owed to Bang.
The filing states that the price per share was $0.2272, described as "equal to 115% of the volume-weighted average price of the Common Stock for the 15 trading days ended October 28, 2026." The award was approved by the issuer's Board of Directors and Compensation Committee. The filing further notes that the transaction "is exempt under Rule 16b-3(d)," which covers acquisitions from the issuer under certain compensatory arrangements.
Following this transaction, Bang's total direct beneficial ownership stands at 440,137 shares of common stock, as reported in Table I of the filing. The filing also discloses that the shares are subject to a six-month contractual lock-up from the grant date. No derivative securities were reported in Table II. The Form 4 was signed by Gihyoun Bang and dated November 19, 2026.
What Was Disclosed
OSR Health CFO Gihyoun Bang disclosed the acquisition of 440,137 common shares on October 29, 2026, at $0.2272 per share in settlement of accrued unpaid salary under the company's 2025 Omnibus Incentive Plan, with a six-month contractual lock-up applying to the shares.



Please wait processing your request...